Zoll Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of
resuscitation devices and related software solutions, announced today
that its facility in Pittsburgh, Pennsylvania that manufacturers and
sells the LifeVest® Wearable Defibrillator, has received
Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS)
Accreditation from Medicare. This designation, in combination with its
ISO 13485 certification, makes ZOLL’s Pittsburgh facility one of the few
healthcare organization facilities to integrate its Medicare
accreditation and ISO 13485 certification into a single accredited
management system.
The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA)
requires all DMEPOS suppliers to meet quality standards for Medicare
accreditation, which is mandatory to maintain National Supplier
Clearinghouse (NSC) billing privileges. DMEPOS accreditation
specifically focuses on standards for administration, financial
management, human resource management, consumer services, performance
management, product safety, and information management. The
accreditation also contains service standards, including intake,
delivery and set-up, training and instruction of the beneficiary and/or
their caregiver, and follow-up service.
"ZOLL continues to demonstrate its commitment to the highest level of
business standards by obtaining the Centers for Medicare and Medicaid
Services DMEPOS Accreditation,” said Richard A. Packer, Chairman and
Chief Executive Officer of ZOLL. "We are pleased that our process and
management systems have enabled us to achieve this milestone.”
The LifeVest durable medical equipment (DME) business model allows a
physician to protect a specific patient by placing a medical order
directly with ZOLL. From this point, ZOLL manages the process to protect
the patient from sudden cardiac arrest through hospital discharge and
recovery at home, including fitting the LifeVest to the specific
patient, educating the patient in the hospital, managing all of the
medical documentation and insurance paperwork, and being available to
address any patient needs once home.
The LifeVest is covered by most health plans in the United States,
including commercial, state, and federal plans. To date, the LifeVest
has been prescribed to more than 18,000 patients. For more information,
go to www.zoll.lifecor.com
or call 1-800-543-3267.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that
help advance the practice of resuscitation and temperature control
therapies for the treatment of critical care patients. With products for
pacing, defibrillation, circulation, temperature management, and fluid
resuscitation, ZOLL provides a comprehensive set of technologies,
including Real CPR Help® and See-Thru CPR®, which
help clinicians, EMS professionals, and lay rescuers resuscitate sudden
cardiac arrest or trauma victims. ZOLL also designs and markets software
that automates the documentation and management of both clinical and
non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The
Company has direct operations, distributor networks, and business
partners throughout the U.S., Canada, Latin America, Europe, the Middle
East and Africa, Asia, and Australia. During 2008 ZOLL marked the 25th
anniversary of the Company’s resuscitation product development. For more
information, visit www.zoll.com.
Certain statements contained in this press release, including
statements regarding the future business of the Company, and other
statements contained herein regarding matters that are not historical
facts, are "forward-looking” statements (as defined in the Private
Securities Litigation Reform Act of 1995). Because such statements are
subject to risks and uncertainties, actual results may differ materially
from those expressed or implied by such forward-looking statements.
Factors that could cause actual results to differ materially from those
expressed or implied by such forward-looking statements include, but are
not limited to, those factors discussed in the section entitled "Risk
Factors” in the Company's Quarterly Report on Form 10-Q filed with the
SEC on August 7, 2009. You should not place undue reliance on the
forward-looking statements in this press release, and the Company
disavows any obligation to update or supplement those statements in the
event of any changes in the facts, circumstances, or expectations that
underlie those statements.
Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill
Road, Chelmsford, MA 01824-4105. ZOLL, LifeVest, Real CPR Help, and
See-Thru CPR are registered trademarks of ZOLL Medical Corporation. All
product names are the property of their respective owners.
